Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genentech, Inc. (NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about Genentech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Genentech Announces Full Year and Fourth Quarter 2008 Results
January 15, 2009
from Business Wire News Releases
BridgewaterEquity.com Free Fundamental Sector & Market Research on DNA, GLW, GD and LMT
January 12, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE). Read More
from Marketwired News Releases
Genentech Announces January 15 Webcast of Financial and Other Business Results
December 22, 2008
from Business Wire News Releases
Beacon Equity Issues Technical Trade Alerts on Biotechnology Stocks: AMGN, CELG, GENZ, DNA, GILD, INCY
December 19, 2008
from PR Newswire
Phase III Study Showed Rituxan® Decreased the Progression of Joint Damage in Patients with Early Rheumatoid Arthritis (RA)
December 19, 2008
from Business Wire News Releases
Zacks Analyst Blog Highlights: Genentech Inc., Hess Corporation, DPL Inc., Lamar Advertising Co., and Cadence Design Systems, Inc.
December 16, 2008
from Business Wire News Releases
Zacks Bull and Bear of the Day Highlights: Genentech, SanDisk, ICICI Bank, Hess Corp. and Lamar Advertising
December 15, 2008
from Business Wire News Releases
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
December 06, 2008
from Business Wire News Releases
Montura Presents Cost Effective BI Solutions With Relational Object Models
December 03, 2008
from Business Wire News Releases
IR Global Rankings 2009: Final Registration Deadline Is Today - November 28, 2008
November 28, 2008
from PR Newswire
IR Global Rankings 2009: Registration FINAL Deadline Today
November 28, 2008
from PR Newswire
Seven Summits Research Releases Comments on GS, DNA, BP, NKE, and CHL
November 24, 2008
from PR Newswire
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival in Advanced Breast Cancer
November 24, 2008
from Business Wire News Releases
Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in a Raptiva Patient
November 17, 2008
from Business Wire News Releases
IR Global Rankings 2009: Registration Period Extended Until November 28, 2008
November 17, 2008
from PR Newswire
Registration Period for the 2009 IR Global Rankings Ends Today
November 14, 2008
from PR Newswire
Last Days to Register
November 13, 2008
from PR Newswire
Final Reminder: Registration Period for the 2009 IR Global Rankings Ends November 14, 2008
November 11, 2008
from PR Newswire
Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival as a First-Line Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
November 07, 2008
First EGFR Targeted and Oral Therapy to Improve Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer Following Initial Treatment Read More
from Business Wire News Releases
Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer
November 03, 2008
from Business Wire News Releases
Biogen Idec Elects to Participate with Genentech in the Development and Commercialization of a Next Generation Anti-CD20 Molecule
October 30, 2008
from Business Wire News Releases
Don't Miss the Chance to Have Your Investor Relations Program Evaluated
October 29, 2008
from PR Newswire
Rituxan Data in Patients with Rheumatoid Arthritis to Be Presented at the American College of Rheumatology Annual Scientific Meeting
October 27, 2008
from Business Wire News Releases
Reminder - Register Your Company Now for the 2009 IR Global Rankings
October 24, 2008
from PR Newswire
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
October 20, 2008
from Business Wire News Releases
Zacks Analyst Blog Highlights: Genentech, Inc., KeyCorp, Fifth Third Bancorp., Comerica Inc. and Altera Corp.
October 17, 2008
from Business Wire News Releases
Seven Summits Research Releases Alerts on CHK, V, DNA, UPS, and TOL
October 16, 2008
from PR Newswire
Genentech Raises Quarterly Profits With Increased Sales of Anti-Cancer Drugs, an Industrial Info News Alert
October 16, 2008
from Marketwired News Releases
Leading Global Companies Have Already Registered for the 2009 IR Global Rankings. Has Yours?
October 15, 2008
from PR Newswire
Genentech Announces Third Quarter 2008 Results
October 14, 2008
- Operating Revenue Increases 17 Percent to $3.4 Billion, Including U.S. Avastin Sales of $704 Million - Read More
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here